SQUEEEEEEEEEAL!!!! Ya piggerpigs are always here tryin' ta polish the tuhrder. She bein' the all time bacon fryin' pain trainer CHOOOO CHOOOOOOOOOOOOOOOOOOOOO!!!!
First Tuesday in February every leap year.
We meet at the bar around the corner from IMGN's headquarters.
I have owned this stock off and on since 2001. For the first time I just don't see a huge upside, which I personally need to invest in biotechs. Would love for someone to convince me otherwise, but I don't think this company is even on the buyout radar, and could drift downward for long time as doors of opportunity continue to shut.
I was lucky to make it out with a profit. I hope everyone makes money on this stock, but it was too damn frustrating. I took my winnings from IMGN and put the money in a different sector (energy). I anticipate oil to go up eventually and will cash in when that happens.
I kept 200 shares in this stock and if the big buy out happens I'll be a part of it.
If they were that excited about 853 we'd see more insider buying. Instead we see Dan Junius selling. Every time he sells bad news follows. I can understand his options are expiring and need to be exercised not to lose. However, if he thought the stock was going to go up, he'd hold it for a year and a day not to suffer the short term tax consequences. I've learned with this stock, when Dan sells you should too.
I agree with that, but also the point of owning volatile and risky biotechs is because of the huge upside potential. I think the huge upside potential is gone from this one. Not saying it won't down the road have some modest success, but I think it will be a long time and will likely go much lower in the meantime, especially in a market correction. The imagineability is gone.
The options are expiring and he needs to exercise them, however, agree why is he immediately disposing of them for a $2.00 gain and paying the short term gain tax consequence versus holding for a year especially if he feels it will go higher? We've learned, every time Day sells their is some bad news around the corner. I should have taken his lead before the earnings call. Thought it would be a great earnings call with the monetization however had never thought we'd have 289 pulled back and sanofi handing a phase 2 candidate back to us. Maybe he's not feeling that great about 853. CLVS has a breakthrough designation for their ovarian candidate. IMGN is going to need that kind of data at ASCO to get investors on board to be excited about their ADC platform.
Biotechbeagle, the next time this stock goes up just get out of it. I'm probably going to dump my measly little 200 remaining shares in this stock the next time that happens. I left a little house money around just in case something big ever happens, but I'm losing faith that something big will ever happen.
Curious someone must have leaked the upgrade/coverage from today and folks were playing the news. Then a) realized the news wasn't that good, and b) are now trying to get out of that position because the pop from the press release isn't happening. I see 6 before 12.
what news, the PR I read had no significant information, which is typical from this co. They never deliver any real news, no real progress. 25 years of almost nothing.
As everyone knows the Baker Brothers seem to have the hot hand in biotech. PCYC was their number 1 holding when it was sold to ABBV and GEVA was #2 when sold to ALXN. They must be feeling good about IMGN 853 in establishing a new large position prior to ASCO!
I hope the brothers are on to something!!
There is a positive IMGN 8K filed today saying there is a milestone payment from NVS..
Sentiment: Strong Buy